A Randomized, Placebo-controlled, Double-blind Trial to Evaluate Efficacy and Safety of Shen-Yuan-Dan Capsules, A Traditional Chinese Medicine, for Treatment of Peri-procedure Myocardial Injury Following Percutaneous Coronary Intervention.
Complement Ther Med 2022;
69:102841. [DOI:
10.1016/j.ctim.2022.102841]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 04/23/2022] [Accepted: 05/10/2022] [Indexed: 11/23/2022] Open